Increased Incidence of Type 1 Diabetes and Co-Existing Thyroid Autoimmunity During the COVID-19 Pandemic in Sweden
(2025) In Acta Pædiatrica- Abstract
AIM: We aimed to investigate if the incidence of type 1 diabetes increased in children during the SARS-CoV-2 pandemic and whether SARS-CoV-2 antibodies were more frequently present at diagnosis compared with healthy individuals. We also examined whether clinical characteristics and coexisting autoimmunity differed between SARS-CoV-2 antibody positive and negative individuals.
METHODS: This retrospective, longitudinal observational study included children aged 0-17 years diagnosed with type 1 diabetes between 01 January 2018 and 31 December 2023 at Skåne University Hospital, Sweden. Blood samples were analysed for SARS-CoV-2 antibodies and islet autoantibodies and compared to analyses of healthy children from the same period.... (More)
AIM: We aimed to investigate if the incidence of type 1 diabetes increased in children during the SARS-CoV-2 pandemic and whether SARS-CoV-2 antibodies were more frequently present at diagnosis compared with healthy individuals. We also examined whether clinical characteristics and coexisting autoimmunity differed between SARS-CoV-2 antibody positive and negative individuals.
METHODS: This retrospective, longitudinal observational study included children aged 0-17 years diagnosed with type 1 diabetes between 01 January 2018 and 31 December 2023 at Skåne University Hospital, Sweden. Blood samples were analysed for SARS-CoV-2 antibodies and islet autoantibodies and compared to analyses of healthy children from the same period. Clinical characteristics and thyroid autoimmunity at onset were collected from medical records.
RESULTS: The incidence of type 1 diabetes increased from 40/100.000 (pre-pandemic) to 53/100.000 (pandemic). Children diagnosed with type 1 diabetes more likely tested positive for SARS-CoV-2 nucleocapsid protein (NCP) antibodies compared to healthy children. The SARS-CoV-2-NCP positive group had a higher prevalence of thyroid autoimmunity compared to the SARS-CoV-2-NCP negative group.
CONCLUSION: The incidence of type 1 diabetes increased during the SARS-CoV-2 pandemic, with a possible connection to COVID-19. Interestingly, children positive for SARS-CoV-2 antibodies at type 1 diabetes diagnosis had a higher likelihood of thyroid autoimmunity compared to children negative for SARS-CoV-2 antibodies.
(Less)
- author
- Anderberg, J
LU
; Carlsson, P
LU
; Lundgren, M
LU
; Elding Larsson, H
LU
and Carlsson, A
LU
- organization
- publishing date
- 2025-12-01
- type
- Contribution to journal
- publication status
- epub
- subject
- in
- Acta Pædiatrica
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:41324147
- scopus:105023523772
- ISSN
- 1651-2227
- DOI
- 10.1111/apa.70388
- language
- English
- LU publication?
- yes
- additional info
- © 2025 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
- id
- 5723cb72-22e7-4508-a673-b151c3645869
- date added to LUP
- 2026-01-30 15:57:30
- date last changed
- 2026-01-31 04:01:18
@article{5723cb72-22e7-4508-a673-b151c3645869,
abstract = {{<p>AIM: We aimed to investigate if the incidence of type 1 diabetes increased in children during the SARS-CoV-2 pandemic and whether SARS-CoV-2 antibodies were more frequently present at diagnosis compared with healthy individuals. We also examined whether clinical characteristics and coexisting autoimmunity differed between SARS-CoV-2 antibody positive and negative individuals.</p><p>METHODS: This retrospective, longitudinal observational study included children aged 0-17 years diagnosed with type 1 diabetes between 01 January 2018 and 31 December 2023 at Skåne University Hospital, Sweden. Blood samples were analysed for SARS-CoV-2 antibodies and islet autoantibodies and compared to analyses of healthy children from the same period. Clinical characteristics and thyroid autoimmunity at onset were collected from medical records.</p><p>RESULTS: The incidence of type 1 diabetes increased from 40/100.000 (pre-pandemic) to 53/100.000 (pandemic). Children diagnosed with type 1 diabetes more likely tested positive for SARS-CoV-2 nucleocapsid protein (NCP) antibodies compared to healthy children. The SARS-CoV-2-NCP positive group had a higher prevalence of thyroid autoimmunity compared to the SARS-CoV-2-NCP negative group.</p><p>CONCLUSION: The incidence of type 1 diabetes increased during the SARS-CoV-2 pandemic, with a possible connection to COVID-19. Interestingly, children positive for SARS-CoV-2 antibodies at type 1 diabetes diagnosis had a higher likelihood of thyroid autoimmunity compared to children negative for SARS-CoV-2 antibodies.</p>}},
author = {{Anderberg, J and Carlsson, P and Lundgren, M and Elding Larsson, H and Carlsson, A}},
issn = {{1651-2227}},
language = {{eng}},
month = {{12}},
publisher = {{Wiley-Blackwell}},
series = {{Acta Pædiatrica}},
title = {{Increased Incidence of Type 1 Diabetes and Co-Existing Thyroid Autoimmunity During the COVID-19 Pandemic in Sweden}},
url = {{http://dx.doi.org/10.1111/apa.70388}},
doi = {{10.1111/apa.70388}},
year = {{2025}},
}